Showing results (491-500 of 753) with videos related to
Sort By:
Pageof 76
Journal of Neuro-Oncology|June 3, 2015
Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiationRifaquat Rahman, Paul J Catalano, David A Reardon, et al.Journal of Neuro-Oncology|February 5, 2019
Local control after brain-directed radiation in patients with cystic versus solid brain metastasesRachel H Brigell, Daniel N Cagney, Allison M Martin, et al.Neuro-Oncology|July 3, 2023
Insulin feedback is a targetable resistance mechanism of PI3K inhibition in glioblastomaEvan K Noch, Laura N Palma, Isaiah Yim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2018
Discovery and Therapeutic Exploitation of Mechanisms of Resistance to MET Inhibitors in GlioblastomaNichola Cruickshanks, Ying Zhang, Sarah Hine, et al.The Lancet. Oncology|February 3, 2020
Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative reportTerri S Armstrong, Linda Dirven, David Arons, et al.Neuro-Oncology|September 2, 2016
Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trialsBenjamin M Ellingson, Robert J Harris, Davis C Woodworth, et al.Neuro-Oncology|October 10, 2024
Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection-Update 1Martin J van den Bent, Enrico Franceschi, Mehdi Touat, et al.Neuro-Oncology|February 5, 2019
A low percentage of metastases in deep brain and temporal lobe structuresTed K Yanagihara, J Ricardo McFaline-Figueroa, Nicholas J Giacalone, et al.Neuro-Oncology|March 28, 2020
Evaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical dataJian Peng, Hao Zhou, Oliver Tang, et al.Oncotarget|May 14, 2016
MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytomaMichael B Miller, Wenya Linda Bi, Lori A Ramkissoon, et al.Pageof 76